Literature DB >> 9573596

Drug dosing adjustments during continuous renal replacement therapies.

T A Golper1, M A Marx.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9573596

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN： 0098-6577            Impact factor:   10.545


× No keyword cloud information.
  9 in total

1.  Is hemodiafiltration ready for broader use?

Authors:  Thomas A Golper
Journal:  Kidney Int       Date:  2015-11       Impact factor: 10.612

Review 2.  Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.

Authors:  Federico Pea; Pierluigi Viale; Federica Pavan; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

3.  Dosing nucleoside reverse transcriptase inhibitors in adults receiving continuous veno-venous hemofiltration.

Authors:  Milena M McLaughlin; Abeer T Ammar; Lana Gerzenshtein; Kimberly K Scarsi
Journal:  Clin Drug Investig       Date:  2015-04       Impact factor: 2.859

4.  Evaluation of nucleoside reverse transcriptase inhibitor dosing during continuous veno-venous hemofiltration.

Authors:  Milena M McLaughlin; Inela Masic; Lana Gerzenshtein
Journal:  Int J Clin Pharm       Date:  2016-11-25

5.  Single-dose pharmacokinetics of cidofovir in continuous venovenous hemofiltration.

Authors:  Matthias G Vossen; Klaus-Bernhard Gattringer; Walter Jäger; Stefanie Kraff; Florian Thalhammer
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

Review 6.  Optimizing the Clinical Use of Vancomycin.

Authors:  Rocío Álvarez; Luis E López Cortés; José Molina; José M Cisneros; Jerónimo Pachón
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

7.  Determinants of ceftazidime clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.

Authors:  G R Matzke; R F Frye; M S Joy; P M Palevsky
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

8.  Appropriate antibiotic dosing in severe sepsis and acute renal failure: factors to consider.

Authors:  Francisco Javier González de Molina; Ricard Ferrer
Journal:  Crit Care       Date:  2011-08-01       Impact factor: 9.097

9.  Pharmacokinetics and Pharmacodynamics of Anti-infective Agents during Continuous Veno-venous Hemofiltration in Critically Ill Patients: Lessons Learned from an Ancillary Study of the IVOIRE Trial.

Authors:  Dominique Breilh; Patrick M Honore; David De Bels; Jason A Roberts; Jean Baptiste Gordien; Catherine Fleureau; Antoine Dewitte; Julien Coquin; Hadrien Rozé; Paul Perez; Rachid Attou; Sebastien Redant; Luc Kugener; Marie-Claude Saux; Herbert D Spapen; Alexandre Ouattara; Olivier Joannes-Boyau
Journal:  J Transl Int Med       Date:  2019-12-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.